Friess Associates LLC Vapotherm Inc Transaction History

Friess Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$8.01 - $12.48 $368,940 - $574,828	-46,060 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$8.7 - $23.46 $1.5 Million - $4.05 Million	-172,501 Reduced 78.93%	46,060 $436,000
Q2 2019 Aug 14, 2019	SELL	$15.75 - $23.0 $204,655 - $298,862	-12,994 Reduced 5.61%	218,561 $5.03 Million
Q1 2019 May 15, 2019	SELL	$16.02 - $22.17 $137,643 - $190,484	-8,592 Reduced 3.58%	231,555 $4.55 Million
Q4 2018 Feb 14, 2019	BUY	$15.98 - $21.0 $3.84 Million - $5.04 Million	240,147 New	240,147 $4.79 Million

1.29M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.